Cholinergic regulation of bone

Journal of Musculoskeletal Neuronal Interactions

Volumn 13, Issue 2, 2013, Pages 124-132

  Eimar, H ^a   Tamimi, I ^b   Murshed, M ^a   Tamimi, F ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Acetylcholine; Bone; Cholinergic; Osteoporosis; Parasympathetic nervous system

Indexed keywords

BOTULINUM TOXIN A; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; INTERLEUKIN 1; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PYRIDOSTIGMINE; RIVASTIGMINE;

ADRENERGIC SYSTEM; ALZHEIMER DISEASE; AUTONOMIC NERVOUS SYSTEM; BONE; BONE DENSITY; BONE DISEASE; BONE REMODELING; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; DRUG MECHANISM; HUMAN; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; LOCUS CERULEUS; MESENCHYMAL STEM CELL; MYASTHENIA GRAVIS; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; POLIOMYELITIS; REVIEW; SIDE EFFECT;

AUTONOMIC PATHWAYS; BONE AND BONES; BONE REMODELING; CENTRAL NERVOUS SYSTEM; HUMANS; OSTEOPOROSIS; PARASYMPATHETIC NERVOUS SYSTEM;

EID: 84878550136     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Schett G, David JP. The multiple faces of autoimmunemediated bone loss. Nat Rev Endocrinol 2010;6:698-706.
2. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003;4:638-49.
3. Sommerfeldt DW, Rubin CT. Biology of bone and how it orchestrates the form and function of the skeleton. Eur Spine J 2001;10:S86-S95.
4. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen JH, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000;100:197-207.
5. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111:305-17.
6. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G. Leptin regulation of bone resorption by the sympathetic nervous system and cart. Nature 2005;434:514-20.
7. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006;124:407-21.
8. Bassett JH, Williams GR. Critical role of the hypothalamic-pituitary-thyroid axis in bone. Bone 2008;43:418-26.
9. Rosen CJ. Bone remodeling, energy metabolism, and the molecular clock. Cell Metab 2008;7:7-10.
10. Shi Y, Oury F, Yadav VK, Wess J, Liu XS, Guo XE, Murshed M, Karsenty G. Signaling through the m3 muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metab 2010;11:231-38.
11. Bajayo A, Bar A, Denes A, Bachar M, Kram V, Attar-Namdar M, Zallone A, Kovacs KJ, Yirmiya R, Bab I. Skeletal parasympathetic innervation communicates central il-1 signals regulating bone mass accrual. Proc Natl Acad Sci U S A 2012;109:15455-60.
12. Kondo H, Takeuchi S, Togari A. Beta-adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species. Am J Physiol Endocrinol Metab 2013;304:E507-15.
13. Loewi O. Humoral transferability of the heart nerve effect. I. Announcement. Pflug Arch Ges Phys 1921; 189:239-42.
14. Nachmansohn D, John HM. On the formation of acetylcholine in the nerve axon. Science 1945;102:250-51.
15. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol 2007;47:699-729.
16. Caulfield MP, Birdsall NJM. International union of pharmacology. Xvii. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998;50:279-90.
17. Johnson RH, Spaulding JM. Disorders of the autonomic nervous system. Chapter 3. The nervous control of the circulation and its investigation. Contemp Neurol Ser 1974:33-58.
18. Caulfield MP. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 1993;58:319-79
19. Taylor P, Radic Z. The cholinesterases-from genes to proteins. Annu Rev Pharmacol 1994;34:281-320.
20. Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A. Nicotinic binding in rat brain: Autoradiographic comparison of [3h]acetylcholine, [3h]nicotine, and [125i]-alphabungarotoxin. J Neurosci 1985;5:1307-15.
21. Mandelzys A, De Koninck P, Cooper E. Agonist and toxin sensitivities of ach-evoked currents on neurons expressing multiple nicotinic ach receptor subunits. J Neurophysiol 1995;74:1212-21.
22. Bernard V, Normand E, Bloch B. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 1992;12:3591-600.
23. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br J Pharmacol 2008;154:1558-71.
24. Proskocil BJ, Sekhon HS, Jia Y, Savchenko V, Blakely RD, Lindstrom J, Spindel ER. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004;145:2498-506.
25. Liu PS, Chen YY, Feng CK, Lin YH, Yu TC. Muscarinic acetylcholine receptors present in human osteoblast and bone tissue. Eur J Pharmacol 2011;650:34-40.
26. En-Nosse M, Hartmann S, Trinkaus K, Alt V, Stigler B, Heiss C, Kilian O, Schnettler R, Lips KS. Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis. Cell Tissue Res 2009;338:203-15.
27. Vogel-Hopker A, Sperling LE, Layer PG. Co-opting functions of cholinesterases in neural, limb and stem cell development. Protein Peptide Lett 2012;19:155-64.
28. Grisaru D, Lev-Lehman E, Shapira M, Chaikin E, Lessing JB, Eldor A, Eckstein F, Soreq H. Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase. Mol Cell Biol 1999;19:788-95.
29. Inkson CA, Brabbs AC, Grewal TS, Skerry TM, Genever PG. Characterization of acetylcholinesterase expression and secretion during osteoblast differentiation. Bone 2004;35:819-27.
30. Sato T, Abe T, Chida D, Nakamoto N, Hori N, Kokabu S, Sakata Y, Tomaru Y, Iwata T, Usui M, Aiko K, Yoda T. Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts. FEBS Lett 2010;584:817-24.
31. Luo L, Bennett T, Jung HH, Ryan AF. Developmental expression of alpha 9 acetylcholine receptor mrna in the rat cochlea and vestibular inner ear. J Comp Neurol 1998;393:320-31.
32. Walker LM, Preston MR, Magnay JL, Thomas PB, El Haj AJ. Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. Bone 2001;28:603-8.
33. Romano SJ, Pugh PC, McIntosh JM, Berg DK. Neuronaltype acetylcholine receptors and regulation of alpha 7 gene expression in vertebrate skeletal muscle. J Neurobiol 1997;32:69-80.
34. Ono Y, Nagata N, Kimura N. Effects of adrenergic and cholinergic stimulations on cyclic nucleotides metabolism in bone of young rat. Endocrinologia Japonica 1978; 25:477-84.
35. Paic F, Igwe JC, Nori R, Kronenberg MS, Franceschetti T, Harrington P, Kuo L, Shin DG, Rowe DW, Harris SE, Kalajzic I. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 2009;45:682-92.
36. Genever PG, Birch MA, Brown E, Skerry TM. Osteoblastderived acetylcholinesterase: A novel mediator of cell-matrix interactions in bone? Bone 1999;24:297-303.
37. Tang J-M, Yuan J, Li Q, Wang J-N, Kong X, Zheng F, Zhang L, Chen L, Guo L-Y, Huang Y-H, Yang J-Y, Chen S-Y. Acetylcholine induces mesenchymal stem cell migration via ca2+/pkc/erk1/2 signal pathway. J Cell Biochem 2012;113:2704-13.
38. Alkondon M, Pereira EFR, Almeida LEF, Randall WR, Albuquerque EX. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in ca1 interneurons of rat hippocampus. Neuropharmacology 2000;39:2726-39.
39. Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R. Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab 2009;27:555-61.
40. Kliemann K, Kneffel M, Bergen I, Kampschulte M, Langheinrich AC, Duerselen L, Ignatius A, Kilian O, Schnettler R, Lips KS. Quantitative analyses of bone composition in acetylcholine receptor m3r and alpha7 knockout mice. Life Sci 2012;91:997-1002.
41. Fujii T, Masai M, Misawa H, Okuda T, Takada-Takatori Y, Moriwaki Y, Haga T, Kawashima K. Acetylcholine synthesis and release in nih3t3 cells coexpressing the high-affinity choline transporter and choline acetyltransferase. J Neurosci Res 2009;87:3024-32.
42. Galea E, Estrada C. Periendothelial acetylcholine synthesis and release in bovine cerebral cortex capillaries. J Cereb Blood Flow Metab 1991;11:868-74.
43. Sisask G, Bjurholm A, Ahmed M, Kreicbergs A. The development of autonomic innervation in bone and joints of the rat. J Auton Nerv Syst 1996;59:27-33.
44. Tien D, Ohara PT, Larson AA, Jasmin L. Vagal afferents are necessary for the establishment but not the maintenance of kainic acid-induced hyperalgesia in mice. Pain 2003;102:39-49.
45. Asmus SE, Parsons S, Landis SC. Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J Neurosci 2000; 20:1495-504.
46. Song D, Jiang X, Zhu S, Li W, Khadka A, Hu J. Denervation impairs bone regeneration during distraction osteogenesis in rabbit tibia lengthening. Acta Orthop 2012; 83:406-10.
47. Frymoyer JW, Pope MH. Fracture healing in the sciatically denervated rat. J Trauma 1977;17:355-61.
48. Aro H, Eerola E, Aho AJ, Penttinen R. Healing of experimental fractures in the denervated limbs of the rat. Clin Orthop Relat Res 1981:211-7.
49. Madsen JE, Hukkanen M, Aune AK, Basran I, Moller JF, Polak JM, Nordsletten L. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop Relat Res 1998:230-40.
50. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349-55.
51. Zaidi M. Skeletal remodeling in health and disease. Nat Med 2007;13:791-801.
52. Callen DJA, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus-mri volumetry confirms widespread limbic atrophy in ad. Neurology 2001;57:1669-74.
53. Raskind MA, Peskind ER, Holmes C, Goldstein DS. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and alzheimer's disease. Biol Psychiat 1999;46:756-65.
54. Buchner DM, Larson EB. Falls and fractures in patients with alzheimer-type dementia. Jama 1987;257:1492-5.
55. Weller I, Schatzker J. Hip fractures and alzheimer's disease in elderly institutionalized canadians. Ann Epidemiol 2004;14:319-24.
56. Weller IMR, Schatzker J. The relation between hip fracture and alzheimer's disease in the canadian national population health survey health institutions data, 1994-1995-a cross-sectional analysis. J Bone Miner Res 2000; 15:S414-S14.
57. Sato Y, Honda Y, Hayashida N, Iwamoto J, Kanoko T, Satoh K. Vitamin k deficiency and osteopenia in elderly women with alzheimer's disease. Arch Phys Med Rehab 2005;86:576-81.
58. Loskutova N, Honea RA, Brooks WM, Burns JM. Reduced limbic and hypothalamic volumes correlate with bone density in early alzheimer's disease. J Alzheimers Dis 2010;20:313-22.
59. Loskutova N, Honea RA, Vidoni ED, Brooks WM, Burns JM. Bone density and brain atrophy in early alzheimer's disease. J Alzheimers Dis 2009;18:777-85.
60. Tan ZS, Seshadri S, Beiser A, Zhang Y, Felson D, Hannan MT, Au R, Wolf PA, Kiel DP. Bone mineral density and the risk of alzheimer disease. Arch Neurol 2005;62:107-11.
61. Rauch F, Schoenau E. The developing bone: Slave or master of its cells and molecules? Pediatr Res 2001; 50:309-14.
62. Turner CH, Forwood MR, Rho JY, Yoshikawa T. Mechanical loading thresholds for lamellar and woven bone formation. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 1994;9:87-97.
63. Stellar E. The physiology of motivation. 1954. Psychol Rev 1994;101:301-11.
64. Buckley NJ, Bonner TI, Brann MR. Localization of a family of muscarinic receptor mrnas in rat brain. J Neurosci 1988;8:4646-52.
65. Geula C, Mesulam MM. Cholinesterases and the pathology of alzheimer disease. Alzheimer Dis Assoc Disord 1995;9(Suppl.2):23-8.
66. Arnaiz GRD, Schneider PG. Calcitonin modifies ligand binding to muscarinic receptor in cns membranes. Regul Peptides 2000;88:21-26.
67. Krueger JM, Fang JD, Ping TS, Chen ZT, Kushikata T, Gardi J. Sleep-a physiologic role for il-1 beta and tnfalpha. Ann N Y Acad Sci 1998;856:148-59.
68. Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 2003; 13:826-34.
69. Bajayo A, Goshen I, Feldman S, Csernus V, Iverfeldt K, Shohami E, Yirmiya R, Bab I. Central il-1 receptor signaling regulates bone growth and mass. Proc Natl Acad Sci U S A 2005;102:12956-61.
70. Caulfield MP. Muscarinic receptors-characterization, coupling and function. Pharmacol Ther 1993;58:319-79
71. Hegde SS, Choppin A, Bonhaus D, Briaud S, Loeb M, Moy TM, Loury D, Eglen RM. Functional role of m2 and m3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol 1997;120:1409-18.
72. Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland m3 muscarinic acetylcholine receptors in patients with primary sjogren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6.
73. Gautam D, Han SJ, Duttaroy A, Mears D, Hamdan FF, Li JH, Cui Y, Jeon J, Wess J. Role of the m3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes Obes Metab 2007;9 Suppl 2:158-69.
74. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst 2000;81:87-96.
75. Hong SJ, Chang CC. Nicotinic actions of oxotremorine on murine skeletal-muscle-evidence against muscarinic modulation of acetylcholine-release. Brain Res 1990; 534:142-48.
76. Matsuoka I, Domino EF. Cholinergic mechanisms in the cat vestibular system. Neuropharmacology 1975;14:201-10.
77. Wang Z, Shi H, Wang H. Functional m3 muscarinic acetylcholine receptors in mammalian hearts. Br J Pharmacol 2004;142:395-408.
78. Gautam D, Heard TS, Cui Y, Miller G, Bloodworth L, Wess J. Cholinergic stimulation of salivary secretion studied with m1 and m3 muscarinic receptor single-and double-knockout mice. Mol Pharmacol 2004;66:260-7.
79. Park K, Haberberger RV, Gordon TP, Jackson MW. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in sjogren's syndrome. Arthritis Rheum-Us 2011;63:1426-34.
80. Arends J, Wagner ML, Willms BL. Cholinergic muscarinic receptor blockade suppresses arginine-induced and exercise-induced growth-hormone secretion in typei diabetic subjects. J Clin Endocr Metab 1988;66:389-94.
81. Agha-Hosseini F, Mirzaii-Dizgah I, Moosavi MS. Relationship of lumbar spine bone mineral density and oral dryness feeling in menopause. Menopause 2011;18:625-8.
82. Moss SE, Klein R, Klein BEK. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol-Chic 2000;118:1264-68.
83. Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T. Does low bone mineral density start in post-teenage years in women with type 1 diabetes? Diabetes Care 2003;26:2365-69.
84. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999;22:1196-200.
85. Bhattacharyya P, Paul R, Ghosh M, Dey R, Barooah N, Islam S, Acharya D, Nag S, Bardhan S. Prevalence of osteoporosis and osteopenia in advanced chronic obstructive pulmonary disease patients. Lung India 2011; 28:184-6.
86. Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000;23:542-9
87. Mirakhur RK, Clarke RS, Elliott J, Dundee JW. Atropine and glycopyrronium premedication. A comparison of the effects on cardiac rate and rhythm during induction of anaesthesia. Anaesthesia 1978;33:906-12.
88. Kesler BS, Canning BJ. Regulation of baseline cholinergic tone in guinea-pig airway smooth muscle. J Physiol-London 1999;518:843-55.
89. Katz S, Weinerman S. Osteoporosis and gastrointestinal disease. Gastroenterol Hepatol (N Y) 2010;6:506-17.
90. Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med Sci Monitor 2009; 15:Cr5-Cr9.
91. Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: Clinical and oculographic features in 240 cases. Neurology 1987;37:371-8.
92. Jeong SH, Choi SH, Kim JY, Koo JW, Kim HJ, Kim JS. Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology 2009;72:1069-76.
93. Nielsen HK, Laurberg P, Brixen K, Mosekilde L. Relations between diurnal-variations in serum osteocalcin, cortisol, parathyroid-hormone, and ionized calcium in normal individuals. Acta Endocrinol-Cop 1991;124:391-98.
94. Pressman MR, Fry JM. Relationship of autonomic nervous system activity to daytime sleepiness and prior sleep. Sleep 1989;12:239-45.
95. Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (pepi) trial. The writing group for the pepi. Jama 1996;276:1389-96.
96. Nikolov R, Kuhl H, Golbs S. Estrogen replacement therapy and alzheimer's disease. Drugs Today (Barc) 1998; 34:927-33.
97. Hollinger JO, Schmitt JM, Hwang K, Buck D. Impact of nicotine on bone healing. J Biomed Mater Res 1999; 45:294-301.
98. Wong PK, Christie JJ, Wark JD. The effects of smoking on bone health. Clin Sci (Lond) 2007;113:233-41.
99. Chen Y, Guo Q, Pan X, Qin L, Zhang P. Smoking and impaired bone healing: Will activation of cholinergic antiinflammatory pathway be the bridge? Int Orthop 2011; 35:1267-70.
100. Zheng LW, Ma L, Cheung LK. Changes in blood perfusion and bone healing induced by nicotine during distraction osteogenesis. Bone 2008;43:355-61.
101. Koenen M, Peter C, Villarroel A, Witzemann V, Sakmann B. Acetylcholine receptor channel subtype directs the innervation pattern of skeletal muscle. EMBO Rep 2005; 6:570-6.
102. Martin RB. The importance of mechanical loading in bone biology and medicine. J Musculoskelet Neuronal Interact 2007;7:48-53.
103. Maselli RA, Wollmann R, Roos R. Function and ultrastructure of the neuromuscular junction in post-polio syndrome. Ann N Y Acad Sci 1995;753:129-37.
104. Mohammad AF, Khan KA, Galvin L, Hardiman O, O'-Connell PG. High incidence of osteoporosis and fractures in an aging post-polio population. Eur Neurol 2009; 62:369-74.
105. Hambleton P. Clostridium-botulinum toxins-a generalreview of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 1992; 239:16-20.
106. Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS. Botox induced muscle paralysis rapidly degrades bone. Bone 2006;38:257-64.
107. Grimston SK, Silva MJ, Civitelli R. Bone loss after temporarily induced muscle paralysis by botox is not fully recovered after 12 weeks. Ann Ny Acad Sci 2007; 1116:444-60.
108. Pouwels S, de Boer A, Javaid MK, Hilton-Jones D, Verschuuren J, Cooper C, Leufkens HG, de Vries F. Fracture rate in patients with myasthenia gravis: The general practice research database. Osteoporos Int 2013;24(2):467-76.
109. Wakata N, Nemoto H, Sugimoto H, Nomoto N, Konno S, Hayashi N, Araki Y, Nakazato A. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. Clin Neurol Neurosurg 2004;106:139-41.
110. D'Amelio P, Grimaldi A, Bernabei P, Pescarmona GP, Isaia G. Immune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans? Bone 2006;39:658-65.
111. Tamimi I, Ojea T, Sanchez-Siles JM, Rojas F, Martin I, Gormaz I, Perez A, Dawid-Milner MS, Mendez L, Tamimi F. Acetylcholinesterase inhibitors and the risk of hip fracture in alzheimer's disease patients: A case-control study. J Bone Miner Res 2012;27:1518-27.
112. Pavalko FM, Norvell SM, Burr DB, Turner CH, Duncan RL, Bidwell JP. A model for mechanotransduction in bone cells: The load-bearing mechanosomes. J Cell Biochem 2003;88:104-12.
113. Moriishi T, Fukuyama R, Ito M, Miyazaki T, Maeno T, Kawai Y, Komori H, Komori T. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of rankl in osteoblasts and sost in osteocytes at unloading. PloS one 2012;7.
114. Nakamura M, Tada Y, Akaishi T, Nakata K. M3 muscarinic receptor mediates regulation of protein secretion in rabbit lacrimal gland. Curr Eye Res 1997;16:614-9.
115. Layden BT, Durai V, Lowe Jr WL. G-protein-coupled receptors, pancreatic islets, and diabetes. Nature Education 2010;9:13.
116. Pietschmann P, Schernthaner G, Luger A. Effect of cholinergic muscarinic receptor blockade on human growth-hormone (gh)-releasing hormone-(1-44)-induced gh secretion in acromegaly and type-i diabetes-mellitus. J Clin Endocr Metab 1986;63:389-93.
117. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD. Bone mineral density measured by dual x-ray absorptiometry in spanish patients with insulin-dependent diabetes mellitus. Calcified Tissue Int 1996;58:316-9.
118. Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 2002;58:266-72.
119. Proskocil BJ, Sekhon HS, Jia YB, Savchenko V, Blakely RD, Lindstrom J, Spindel ER. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004; 145:2498-506.
120. Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C, Mark GP, Grando SA, Spindel ER. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res 2007;67:3936-44.
121. OBrien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Digest Dis Sci 1997;42:26-33.
122. Monzani D, Genovese E, Marrara A, Presutti L, Gherpelli C, Panzetti P, Forghieri M. Stimulation of the cholinergic neurotransmissions enhances the efficacy of vestibular rehabilitation. Acta Otorhinolaryngol Ital 2010;30:11-9.